BridgeBio Pharma, Inc. (BBIO)
Pharmaceutical Preparations
Latest Price
$72.38
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 14.11M | $1.05B | 7.23% | -- | 2026-06-30 |
| Kohlberg Kravis Roberts & Co. L.P. | 13.26M | $987.0M | 6.79% | -- | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 10.74M | $800.0M | 5.50% | -- | 2026-06-30 |
| BlackRock, Inc. | 10.29M | $766.0M | 5.27% | -3.92M | 2026-06-30 |
| VIKING GLOBAL INVESTORS LP | 9.95M | $741.0M | 5.09% | -4.44M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.90M | $588.0M | 4.04% | +139.5K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.66M | $570.0M | 3.92% | -423.9K | 2026-06-30 |
| JANE STREET GROUP, LLC | 6.11M | $455.0M | 3.13% | +1.18M | 2026-06-30 |
| UBS Group AG | 5.65M | $420.0M | 2.89% | -241.0K | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.31M | $395.0M | 2.72% | +2.82M | 2026-06-30 |